Published in Blood Weekly, October 3rd, 2002
"We used a "positive" (CD34) and "negative" (CD19) double-selection method to improve the efficacy of "single purging" of hematopoietic harvests in poor-prognosis lymphoproliferative disorders," explained Albert Altes and colleagues at the University of Barcelona and Hospital Duran i Reynals in Barcelona.
Patients treated with double-purged grafts had lower relapse risk although they were more likely to suffer from severe post-transplant...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.